🔎 Trials Near Me

Domov › Kronična vnetna demielinizirajoča poliradikuloneuropatija › Florida

Klinične študije za Kronična vnetna demielinizirajoča poliradikuloneuropatija v Florida

11 študij za Kronična vnetna demielinizirajoča poliradikuloneuropatija išče udeležence na lokacijah v Florida.

Mesta v Florida

Uradno besedilo študije (angleško)

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Site Number - 1603, Maitland
  • Site Number - 1606, Miami
  • Site Number - 1617, Ormond Beach
  • in še 2
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07032662

Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Healthcare Innovations Institute Inc, Coral Springs
  • ALS Center at the University of Miami, Miami
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05327114

A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  • Gables Neurology, Miami
  • Aqualane Clinical Research, Naples
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07091630

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  • Homestead Associates in Research Inc, Homestead
  • Visionary Investigators Network, Miami
  • University of South Florida, Tampa
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06920004

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Nova Clinical Research - Bradenton- Site Number : 8400044, Bradenton
  • Research by Design, LLC- Site Number : 8400053, Miami Lakes
  • AdventHealth Orlando- Site Number : 8400006, Orlando
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06290141

A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • Quantix Research, Miami
  • USF Health - Morsani Center for Advanced Healthcare, Tampa
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06752356

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  • GC2402 Study Site 109, Coral Springs
  • GC2402 Study Site 103, Port Charlotte
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07540221

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  • Clinical Study Site, Maitland
  • Clinical Study Site, Tampa
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06858579

A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • UF Health Neurology - Jacksonville, Jacksonville
  • Visionary Investigators Network, Miami
  • University of South Florida, Tampa
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 23. apr. 2026 · NCT06798012

A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • Neurology Associates, Maitland
  • Knight Neurology, Rockledge
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT06747351

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

  • Nova Clinical Research, LLC, Bradenton
  • Suncoast Neuroscience Associates, Inc., St. Petersburg
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 21. nov. 2025 · NCT06538064

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.